BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 37212698)

  • 21. p40 (ΔNp63) is superior to p63 for the diagnosis of pulmonary squamous cell carcinoma.
    Bishop JA; Teruya-Feldstein J; Westra WH; Pelosi G; Travis WD; Rekhtman N
    Mod Pathol; 2012 Mar; 25(3):405-15. PubMed ID: 22056955
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of napsin A, cytokeratin 5/6, p63, and thyroid transcription factor 1 in adenocarcinoma versus squamous cell carcinoma of the lung.
    Whithaus K; Fukuoka J; Prihoda TJ; Jagirdar J
    Arch Pathol Lab Med; 2012 Feb; 136(2):155-62. PubMed ID: 22288962
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sex determining region Y-Box 2 (SOX2) is a potential cell-lineage gene highly expressed in the pathogenesis of squamous cell carcinomas of the lung.
    Yuan P; Kadara H; Behrens C; Tang X; Woods D; Solis LM; Huang J; Spinola M; Dong W; Yin G; Fujimoto J; Kim E; Xie Y; Girard L; Moran C; Hong WK; Minna JD; Wistuba II
    PLoS One; 2010 Feb; 5(2):e9112. PubMed ID: 20161759
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of thyroid transcription factor-1 expression by 2 monoclonal antibodies in pulmonary and nonpulmonary primary tumors.
    Matoso A; Singh K; Jacob R; Greaves WO; Tavares R; Noble L; Resnick MB; Delellis RA; Wang LJ
    Appl Immunohistochem Mol Morphol; 2010 Mar; 18(2):142-9. PubMed ID: 19887917
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An immunohistochemical comparison of two TTF-1 monoclonal antibodies in atypical squamous lesions and sarcomatoid carcinoma of the lung, and pleural malignant mesothelioma.
    Klebe S; Swalling A; Jonavicius L; Henderson DW
    J Clin Pathol; 2016 Feb; 69(2):136-41. PubMed ID: 26281863
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential expression of various clones of estrogen receptor in cell block preparation of lung adenocarcinoma.
    Hakima L; Schlesinger K; Sunkara J; Karabakhtsian RG
    Diagn Cytopathol; 2018 May; 46(5):390-394. PubMed ID: 29465823
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Isolation of cancer stem like cells from human adenosquamous carcinoma of the lung supports a monoclonal origin from a multipotential tissue stem cell.
    Mather JP; Roberts PE; Pan Z; Chen F; Hooley J; Young P; Xu X; Smith DH; Easton A; Li P; Bonvini E; Koenig S; Moore PA
    PLoS One; 2013; 8(12):e79456. PubMed ID: 24324581
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A qualitative transcriptional signature for the histological reclassification of lung squamous cell carcinomas and adenocarcinomas.
    Li X; Shi G; Chu Q; Jiang W; Liu Y; Zhang S; Zhang Z; Wei Z; He F; Guo Z; Qi L
    BMC Genomics; 2019 Nov; 20(1):881. PubMed ID: 31752667
    [TBL] [Abstract][Full Text] [Related]  

  • 29. ΔNp63, CK5/6, TTF-1 and napsin A, a reliable panel to subtype non-small cell lung cancer in biopsy specimens.
    Zhao W; Wang H; Peng Y; Tian B; Peng L; Zhang DC
    Int J Clin Exp Pathol; 2014; 7(7):4247-53. PubMed ID: 25120805
    [TBL] [Abstract][Full Text] [Related]  

  • 30. P63 in pulmonary epithelium, pulmonary squamous neoplasms, and other pulmonary tumors.
    Wang BY; Gil J; Kaufman D; Gan L; Kohtz DS; Burstein DE
    Hum Pathol; 2002 Sep; 33(9):921-6. PubMed ID: 12378518
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunohistochemical characteristics of brain metastases and corresponding primary lung cancer.
    Marinova Marinova D; Vitkov Mekov E; Gosheva Dimitrova D; Todorov Titorenkov P; Martinov Mihailov M; Slavov Nachev S; Milosheva Youroukova V; Temelkov Kostadinov D; Georgieva Slavova Y
    J BUON; 2019; 24(4):1626-1637. PubMed ID: 31646818
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Use of monoclonal antibodies to keratin 7 in the differential diagnosis of adenocarcinomas.
    Ramaekers F; van Niekerk C; Poels L; Schaafsma E; Huijsmans A; Robben H; Schaart G; Vooijs P
    Am J Pathol; 1990 Mar; 136(3):641-55. PubMed ID: 1690512
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expressions of Thyroid Transcription Factor-1, Napsin A, p40, p63, CK5/6 and Desmocollin-3 in Non-Small Cell Lung Cancer, as Revealed by Imprint Cytology Using a Malinol-Based Cell-Transfer Technique.
    Kawai T; Tominaga S; Hiroi S; Kameda K; Ogata S; Nakashima H; Ozeki Y; Nakanishi K
    Acta Cytol; 2015; 59(6):457-64. PubMed ID: 26696549
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Contribution of immunohistochemistry in the differential diagnosis of non-small cell lung carcinomas on small biopsy samples.
    Stojsic J; Jovanic I; Markovic J; Gajic M
    J BUON; 2013; 18(1):176-87. PubMed ID: 23613404
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Demonstration of CDX2 is highly antibody dependant.
    Borrisholt M; Nielsen S; Vyberg M
    Appl Immunohistochem Mol Morphol; 2013 Jan; 21(1):64-72. PubMed ID: 22595949
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of calretinin, thrombomodulin, keratin 5, and mesothelin in lung carcinomas of different types: an immunohistochemical analysis of 596 tumors in comparison with epithelioid mesotheliomas of the pleura.
    Miettinen M; Sarlomo-Rikala M
    Am J Surg Pathol; 2003 Feb; 27(2):150-8. PubMed ID: 12548160
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ΔNp63 (p40) distribution inside lung cancer: a driver biomarker approach to tumor characterization.
    Pelosi G; Rossi G; Cavazza A; Righi L; Maisonneuve P; Barbareschi M; Graziano P; Pastorino U; Garassino M; de Braud F; Papotti M
    Int J Surg Pathol; 2013 Jun; 21(3):229-39. PubMed ID: 23486764
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinicopathological significance of the expression of PD-L1 in non-small cell lung cancer.
    Montero MA; Aricak O; Kis L; Yoshikawa A; De Petris L; Grundberg O; Pham HHN; Roden AC; Fukuoka J; Attanoos R; Guijarro R; Alarcón F; Lindström K; Ortiz-Villalón C
    Ann Diagn Pathol; 2021 Apr; 51():151701. PubMed ID: 33485052
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Utility of 10 immunohistochemical markers including novel markers (desmocollin-3, glypican 3, S100A2, S100A7, and Sox-2) for differential diagnosis of squamous cell carcinoma from adenocarcinoma of the Lung.
    Tsuta K; Tanabe Y; Yoshida A; Takahashi F; Maeshima AM; Asamura H; Tsuda H
    J Thorac Oncol; 2011 Jul; 6(7):1190-9. PubMed ID: 21623236
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Use of dual-marker staining to differentiate between lung squamous cell carcinoma and adenocarcinoma.
    Guo R; Tian Y; Zhang N; Huang H; Huang Y; Yang J
    J Int Med Res; 2020 Apr; 48(4):300060519893867. PubMed ID: 31880186
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.